Its hard to believe its been a full year since Abbott closed its acquisition of Alere, considering what a contentious deal it was and how hard Abbott fought last year to get out of it. When the acquisition finally did close, Will All the Abb... Read More >

Illumina reported recently that its revenues for the third quarter grew 20 percent year over year, driven by growth across its sequencing and microarray products. For the three months ended Sept. 30, the San Diego-based company reported $85... Read More >

NeoGenomics recently announced a definitive agreement to acquire clinical oncology laboratory Genoptix for $125 million in cash and 1 million shares of NeoGenomics stock. Based in Carlsbad, California, Genoptix specializes on hematology and... Read More >

Genomics services provider GeneWiz and bioinformatics and genomics company Nashville Biosciences announced recently at the American Society of Human Genetics conference that they are collaborating to combine Nashville Bios BioVU biobank wit... Read More >

Roche said recently that its diagnostics division revenues grew 6 percent in the first nine months of 2018, driven mainly by growing demand for its immunodiagnostics solutions. For the nine months ended Sept. 30, the Basel, Switzerland-base... Read More >

Roche said recently that its diagnostics division revenues grew 6 percent in the first nine months of 2018, driven mainly by growing demand for its immunodiagnostics solutions. For the nine months ended Sept. 30, the Basel, Switzerland-base... Read More >

Thermo Fisher Scientific announced recentlythat it has received CE-IVD marking for its Oncomine Dx Target Test. The next-generation sequencing-based test is designed to detect 46 cancer-driver gene variants associated with approved and inves... Read More >

Abbott recently said that its Diagnostics business grew sales 43 percent year over year. For the three months ended Sept. 30, 2018 the Abbott Park, Illinois-based firm reported overall revenues of $7.66 billion, up 12 percent on a reported... Read More >

Thermo Fisher Scientific said recently that its third quarter revenues grew 16 percent, driven by growth across its four business segments. We continued our strong growth momentum and delivered another excellent quarter in Q3, said Presiden... Read More >

Recently, CEC and WuXi AppTec announced the establishment of a joint venture company, Zhongdian Yaoming, to jointly cultivate the health care big data industry.The two companies will provide health care data solutions for pharmaceutical comp... Read More >